0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Wearable Drug Delivery Systems Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-1N10830
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Wearable Drug Delivery Systems Market Research Report 2022
BUY CHAPTERS

Global Wearable Drug Delivery Systems Market Research Report 2025

Code: QYRE-Auto-1N10830
Report
March 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Wearable Drug Delivery Systems Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Wearable Drug Delivery Systems Market

Wearable Drug Delivery Systems Market

The global market for Wearable Drug Delivery Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wearable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Drug Delivery Systems.
The Wearable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Wearable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Wearable Drug Delivery Systems Market Report

Report Metric Details
Report Name Wearable Drug Delivery Systems Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Home Care
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation, West Pharma, Eitan Medical, BD Medical, Noble International, Insulet, Amgen, Roche, CeQur, ScPharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Wearable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Wearable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Wearable Drug Delivery Systems Market report?

Ans: The main players in the Wearable Drug Delivery Systems Market are Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation, West Pharma, Eitan Medical, BD Medical, Noble International, Insulet, Amgen, Roche, CeQur, ScPharmaceuticals

What are the Application segmentation covered in the Wearable Drug Delivery Systems Market report?

Ans: The Applications covered in the Wearable Drug Delivery Systems Market report are Hospital, Clinic, Home Care, Others

What are the Type segmentation covered in the Wearable Drug Delivery Systems Market report?

Ans: The Types covered in the Wearable Drug Delivery Systems Market report are Electronical Drug Delivery Devices, Mechanical Drug Delivery Devices

Recommended Reports

Drug Delivery Devices

Wearable Medical Devices

Innovative Drug Delivery

1 Wearable Drug Delivery Systems Market Overview
1.1 Product Definition
1.2 Wearable Drug Delivery Systems by Type
1.2.1 Global Wearable Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronical Drug Delivery Devices
1.2.3 Mechanical Drug Delivery Devices
1.3 Wearable Drug Delivery Systems by Application
1.3.1 Global Wearable Drug Delivery Systems Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Wearable Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Wearable Drug Delivery Systems Revenue 2020-2031
1.4.2 Global Wearable Drug Delivery Systems Sales 2020-2031
1.4.3 Global Wearable Drug Delivery Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Wearable Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Wearable Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Wearable Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Wearable Drug Delivery Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Wearable Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wearable Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Drug Delivery Systems, Product Type & Application
2.7 Global Key Manufacturers of Wearable Drug Delivery Systems, Date of Enter into This Industry
2.8 Global Wearable Drug Delivery Systems Market Competitive Situation and Trends
2.8.1 Global Wearable Drug Delivery Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Wearable Drug Delivery Systems Players Market Share by Revenue
2.8.3 Global Wearable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Wearable Drug Delivery Systems Market Scenario by Region
3.1 Global Wearable Drug Delivery Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Wearable Drug Delivery Systems Sales by Region: 2020-2031
3.2.1 Global Wearable Drug Delivery Systems Sales by Region: 2020-2025
3.2.2 Global Wearable Drug Delivery Systems Sales by Region: 2026-2031
3.3 Global Wearable Drug Delivery Systems Revenue by Region: 2020-2031
3.3.1 Global Wearable Drug Delivery Systems Revenue by Region: 2020-2025
3.3.2 Global Wearable Drug Delivery Systems Revenue by Region: 2026-2031
3.4 North America Wearable Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.4.3 North America Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Wearable Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.5.3 Europe Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Drug Delivery Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Wearable Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Wearable Drug Delivery Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Wearable Drug Delivery Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Wearable Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.7.3 Latin America Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Wearable Drug Delivery Systems Sales by Type (2020-2031)
4.1.1 Global Wearable Drug Delivery Systems Sales by Type (2020-2025)
4.1.2 Global Wearable Drug Delivery Systems Sales by Type (2026-2031)
4.1.3 Global Wearable Drug Delivery Systems Sales Market Share by Type (2020-2031)
4.2 Global Wearable Drug Delivery Systems Revenue by Type (2020-2031)
4.2.1 Global Wearable Drug Delivery Systems Revenue by Type (2020-2025)
4.2.2 Global Wearable Drug Delivery Systems Revenue by Type (2026-2031)
4.2.3 Global Wearable Drug Delivery Systems Revenue Market Share by Type (2020-2031)
4.3 Global Wearable Drug Delivery Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Wearable Drug Delivery Systems Sales by Application (2020-2031)
5.1.1 Global Wearable Drug Delivery Systems Sales by Application (2020-2025)
5.1.2 Global Wearable Drug Delivery Systems Sales by Application (2026-2031)
5.1.3 Global Wearable Drug Delivery Systems Sales Market Share by Application (2020-2031)
5.2 Global Wearable Drug Delivery Systems Revenue by Application (2020-2031)
5.2.1 Global Wearable Drug Delivery Systems Revenue by Application (2020-2025)
5.2.2 Global Wearable Drug Delivery Systems Revenue by Application (2026-2031)
5.2.3 Global Wearable Drug Delivery Systems Revenue Market Share by Application (2020-2031)
5.3 Global Wearable Drug Delivery Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gerresheimer
6.1.1 Gerresheimer Company Information
6.1.2 Gerresheimer Description and Business Overview
6.1.3 Gerresheimer Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gerresheimer Wearable Drug Delivery Systems Product Portfolio
6.1.5 Gerresheimer Recent Developments/Updates
6.2 Owen Mumford
6.2.1 Owen Mumford Company Information
6.2.2 Owen Mumford Description and Business Overview
6.2.3 Owen Mumford Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Owen Mumford Wearable Drug Delivery Systems Product Portfolio
6.2.5 Owen Mumford Recent Developments/Updates
6.3 Sonceboz
6.3.1 Sonceboz Company Information
6.3.2 Sonceboz Description and Business Overview
6.3.3 Sonceboz Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sonceboz Wearable Drug Delivery Systems Product Portfolio
6.3.5 Sonceboz Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics Wearable Drug Delivery Systems Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 Ypsomed
6.5.1 Ypsomed Company Information
6.5.2 Ypsomed Description and Business Overview
6.5.3 Ypsomed Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ypsomed Wearable Drug Delivery Systems Product Portfolio
6.5.5 Ypsomed Recent Developments/Updates
6.6 Elcam Medical
6.6.1 Elcam Medical Company Information
6.6.2 Elcam Medical Description and Business Overview
6.6.3 Elcam Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Elcam Medical Wearable Drug Delivery Systems Product Portfolio
6.6.5 Elcam Medical Recent Developments/Updates
6.7 Enable Injections
6.7.1 Enable Injections Company Information
6.7.2 Enable Injections Description and Business Overview
6.7.3 Enable Injections Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enable Injections Wearable Drug Delivery Systems Product Portfolio
6.7.5 Enable Injections Recent Developments/Updates
6.8 Unilife Corporation
6.8.1 Unilife Corporation Company Information
6.8.2 Unilife Corporation Description and Business Overview
6.8.3 Unilife Corporation Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Unilife Corporation Wearable Drug Delivery Systems Product Portfolio
6.8.5 Unilife Corporation Recent Developments/Updates
6.9 West Pharma
6.9.1 West Pharma Company Information
6.9.2 West Pharma Description and Business Overview
6.9.3 West Pharma Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 West Pharma Wearable Drug Delivery Systems Product Portfolio
6.9.5 West Pharma Recent Developments/Updates
6.10 Eitan Medical
6.10.1 Eitan Medical Company Information
6.10.2 Eitan Medical Description and Business Overview
6.10.3 Eitan Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eitan Medical Wearable Drug Delivery Systems Product Portfolio
6.10.5 Eitan Medical Recent Developments/Updates
6.11 BD Medical
6.11.1 BD Medical Company Information
6.11.2 BD Medical Description and Business Overview
6.11.3 BD Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BD Medical Wearable Drug Delivery Systems Product Portfolio
6.11.5 BD Medical Recent Developments/Updates
6.12 Noble International
6.12.1 Noble International Company Information
6.12.2 Noble International Description and Business Overview
6.12.3 Noble International Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Noble International Wearable Drug Delivery Systems Product Portfolio
6.12.5 Noble International Recent Developments/Updates
6.13 Insulet
6.13.1 Insulet Company Information
6.13.2 Insulet Description and Business Overview
6.13.3 Insulet Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Insulet Wearable Drug Delivery Systems Product Portfolio
6.13.5 Insulet Recent Developments/Updates
6.14 Amgen
6.14.1 Amgen Company Information
6.14.2 Amgen Description and Business Overview
6.14.3 Amgen Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Amgen Wearable Drug Delivery Systems Product Portfolio
6.14.5 Amgen Recent Developments/Updates
6.15 Roche
6.15.1 Roche Company Information
6.15.2 Roche Description and Business Overview
6.15.3 Roche Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Roche Wearable Drug Delivery Systems Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 CeQur
6.16.1 CeQur Company Information
6.16.2 CeQur Description and Business Overview
6.16.3 CeQur Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CeQur Wearable Drug Delivery Systems Product Portfolio
6.16.5 CeQur Recent Developments/Updates
6.17 ScPharmaceuticals
6.17.1 ScPharmaceuticals Company Information
6.17.2 ScPharmaceuticals Description and Business Overview
6.17.3 ScPharmaceuticals Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ScPharmaceuticals Wearable Drug Delivery Systems Product Portfolio
6.17.5 ScPharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Drug Delivery Systems Industry Chain Analysis
7.2 Wearable Drug Delivery Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Drug Delivery Systems Production Mode & Process Analysis
7.4 Wearable Drug Delivery Systems Sales and Marketing
7.4.1 Wearable Drug Delivery Systems Sales Channels
7.4.2 Wearable Drug Delivery Systems Distributors
7.5 Wearable Drug Delivery Systems Customer Analysis
8 Wearable Drug Delivery Systems Market Dynamics
8.1 Wearable Drug Delivery Systems Industry Trends
8.2 Wearable Drug Delivery Systems Market Drivers
8.3 Wearable Drug Delivery Systems Market Challenges
8.4 Wearable Drug Delivery Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Wearable Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Wearable Drug Delivery Systems Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Wearable Drug Delivery Systems Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Wearable Drug Delivery Systems Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Wearable Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Wearable Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Wearable Drug Delivery Systems Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Wearable Drug Delivery Systems Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Wearable Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Wearable Drug Delivery Systems, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Wearable Drug Delivery Systems, Product Type & Application
 Table 12. Global Key Manufacturers of Wearable Drug Delivery Systems, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Wearable Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Drug Delivery Systems as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Wearable Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Wearable Drug Delivery Systems Sales by Region (2020-2025) & (K Units)
 Table 18. Global Wearable Drug Delivery Systems Sales Market Share by Region (2020-2025)
 Table 19. Global Wearable Drug Delivery Systems Sales by Region (2026-2031) & (K Units)
 Table 20. Global Wearable Drug Delivery Systems Sales Market Share by Region (2026-2031)
 Table 21. Global Wearable Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Wearable Drug Delivery Systems Revenue Market Share by Region (2020-2025)
 Table 23. Global Wearable Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Wearable Drug Delivery Systems Revenue Market Share by Region (2026-2031)
 Table 25. North America Wearable Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Wearable Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 27. North America Wearable Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 28. North America Wearable Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Wearable Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Wearable Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Wearable Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Wearable Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Wearable Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Wearable Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Wearable Drug Delivery Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Wearable Drug Delivery Systems Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Wearable Drug Delivery Systems Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Wearable Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Wearable Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Wearable Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Wearable Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Wearable Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Wearable Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Wearable Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Wearable Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Wearable Drug Delivery Systems Sales (K Units) by Type (2020-2025)
 Table 51. Global Wearable Drug Delivery Systems Sales (K Units) by Type (2026-2031)
 Table 52. Global Wearable Drug Delivery Systems Sales Market Share by Type (2020-2025)
 Table 53. Global Wearable Drug Delivery Systems Sales Market Share by Type (2026-2031)
 Table 54. Global Wearable Drug Delivery Systems Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Wearable Drug Delivery Systems Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Wearable Drug Delivery Systems Revenue Market Share by Type (2020-2025)
 Table 57. Global Wearable Drug Delivery Systems Revenue Market Share by Type (2026-2031)
 Table 58. Global Wearable Drug Delivery Systems Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Wearable Drug Delivery Systems Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Wearable Drug Delivery Systems Sales (K Units) by Application (2020-2025)
 Table 61. Global Wearable Drug Delivery Systems Sales (K Units) by Application (2026-2031)
 Table 62. Global Wearable Drug Delivery Systems Sales Market Share by Application (2020-2025)
 Table 63. Global Wearable Drug Delivery Systems Sales Market Share by Application (2026-2031)
 Table 64. Global Wearable Drug Delivery Systems Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Wearable Drug Delivery Systems Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Wearable Drug Delivery Systems Revenue Market Share by Application (2020-2025)
 Table 67. Global Wearable Drug Delivery Systems Revenue Market Share by Application (2026-2031)
 Table 68. Global Wearable Drug Delivery Systems Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Wearable Drug Delivery Systems Price (US$/Unit) by Application (2026-2031)
 Table 70. Gerresheimer Company Information
 Table 71. Gerresheimer Description and Business Overview
 Table 72. Gerresheimer Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Gerresheimer Wearable Drug Delivery Systems Product
 Table 74. Gerresheimer Recent Developments/Updates
 Table 75. Owen Mumford Company Information
 Table 76. Owen Mumford Description and Business Overview
 Table 77. Owen Mumford Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Owen Mumford Wearable Drug Delivery Systems Product
 Table 79. Owen Mumford Recent Developments/Updates
 Table 80. Sonceboz Company Information
 Table 81. Sonceboz Description and Business Overview
 Table 82. Sonceboz Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sonceboz Wearable Drug Delivery Systems Product
 Table 84. Sonceboz Recent Developments/Updates
 Table 85. United Therapeutics Company Information
 Table 86. United Therapeutics Description and Business Overview
 Table 87. United Therapeutics Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. United Therapeutics Wearable Drug Delivery Systems Product
 Table 89. United Therapeutics Recent Developments/Updates
 Table 90. Ypsomed Company Information
 Table 91. Ypsomed Description and Business Overview
 Table 92. Ypsomed Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ypsomed Wearable Drug Delivery Systems Product
 Table 94. Ypsomed Recent Developments/Updates
 Table 95. Elcam Medical Company Information
 Table 96. Elcam Medical Description and Business Overview
 Table 97. Elcam Medical Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Elcam Medical Wearable Drug Delivery Systems Product
 Table 99. Elcam Medical Recent Developments/Updates
 Table 100. Enable Injections Company Information
 Table 101. Enable Injections Description and Business Overview
 Table 102. Enable Injections Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Enable Injections Wearable Drug Delivery Systems Product
 Table 104. Enable Injections Recent Developments/Updates
 Table 105. Unilife Corporation Company Information
 Table 106. Unilife Corporation Description and Business Overview
 Table 107. Unilife Corporation Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Unilife Corporation Wearable Drug Delivery Systems Product
 Table 109. Unilife Corporation Recent Developments/Updates
 Table 110. West Pharma Company Information
 Table 111. West Pharma Description and Business Overview
 Table 112. West Pharma Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. West Pharma Wearable Drug Delivery Systems Product
 Table 114. West Pharma Recent Developments/Updates
 Table 115. Eitan Medical Company Information
 Table 116. Eitan Medical Description and Business Overview
 Table 117. Eitan Medical Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Eitan Medical Wearable Drug Delivery Systems Product
 Table 119. Eitan Medical Recent Developments/Updates
 Table 120. BD Medical Company Information
 Table 121. BD Medical Description and Business Overview
 Table 122. BD Medical Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BD Medical Wearable Drug Delivery Systems Product
 Table 124. BD Medical Recent Developments/Updates
 Table 125. Noble International Company Information
 Table 126. Noble International Description and Business Overview
 Table 127. Noble International Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Noble International Wearable Drug Delivery Systems Product
 Table 129. Noble International Recent Developments/Updates
 Table 130. Insulet Company Information
 Table 131. Insulet Description and Business Overview
 Table 132. Insulet Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Insulet Wearable Drug Delivery Systems Product
 Table 134. Insulet Recent Developments/Updates
 Table 135. Amgen Company Information
 Table 136. Amgen Description and Business Overview
 Table 137. Amgen Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Amgen Wearable Drug Delivery Systems Product
 Table 139. Amgen Recent Developments/Updates
 Table 140. Roche Company Information
 Table 141. Roche Description and Business Overview
 Table 142. Roche Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Roche Wearable Drug Delivery Systems Product
 Table 144. Roche Recent Developments/Updates
 Table 145. CeQur Company Information
 Table 146. CeQur Description and Business Overview
 Table 147. CeQur Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. CeQur Wearable Drug Delivery Systems Product
 Table 149. CeQur Recent Developments/Updates
 Table 150. ScPharmaceuticals Company Information
 Table 151. ScPharmaceuticals Description and Business Overview
 Table 152. ScPharmaceuticals Wearable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. ScPharmaceuticals Wearable Drug Delivery Systems Product
 Table 154. ScPharmaceuticals Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Wearable Drug Delivery Systems Distributors List
 Table 158. Wearable Drug Delivery Systems Customers List
 Table 159. Wearable Drug Delivery Systems Market Trends
 Table 160. Wearable Drug Delivery Systems Market Drivers
 Table 161. Wearable Drug Delivery Systems Market Challenges
 Table 162. Wearable Drug Delivery Systems Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Wearable Drug Delivery Systems
 Figure 2. Global Wearable Drug Delivery Systems Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Wearable Drug Delivery Systems Market Share by Type: 2024 & 2031
 Figure 4. Electronical Drug Delivery Devices Product Picture
 Figure 5. Mechanical Drug Delivery Devices Product Picture
 Figure 6. Global Wearable Drug Delivery Systems Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Wearable Drug Delivery Systems Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Home Care
 Figure 11. Others
 Figure 12. Global Wearable Drug Delivery Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Wearable Drug Delivery Systems Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Wearable Drug Delivery Systems Sales (2020-2031) & (K Units)
 Figure 15. Global Wearable Drug Delivery Systems Average Price (US$/Unit) & (2020-2031)
 Figure 16. Wearable Drug Delivery Systems Report Years Considered
 Figure 17. Wearable Drug Delivery Systems Sales Share by Manufacturers in 2024
 Figure 18. Global Wearable Drug Delivery Systems Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Wearable Drug Delivery Systems Players: Market Share by Revenue in Wearable Drug Delivery Systems in 2024
 Figure 20. Wearable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Wearable Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Wearable Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 23. North America Wearable Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Wearable Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 27. Europe Wearable Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Wearable Drug Delivery Systems Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Wearable Drug Delivery Systems Revenue Market Share by Region (2020-2031)
 Figure 35. China Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Wearable Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Wearable Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Wearable Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Wearable Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Wearable Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Wearable Drug Delivery Systems by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Wearable Drug Delivery Systems by Type (2020-2031)
 Figure 57. Global Wearable Drug Delivery Systems Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Wearable Drug Delivery Systems by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Wearable Drug Delivery Systems by Application (2020-2031)
 Figure 60. Global Wearable Drug Delivery Systems Price (US$/Unit) by Application (2020-2031)
 Figure 61. Wearable Drug Delivery Systems Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart